11 January 2017 - Cigna, a top health insurer, is dropping coverage of the EpiPen.

The lifesaving allergy medication has been a flash point for debates over rising drug costs. Manufacturer Mylan (MYL) jacked up the price of the EpiPen by more than 400% since 2009, and was forced to develop a generic alternative amid national outrage.

Cigna now says it will only cover the half-priced generic version, which launched in December.

"The generic version, available now in pharmacies, has the same drug formulation and device functionality as the branded medication, but at a substantial cost savings," Cigna spokeswoman Karen Eldred said.

Read CNN Money article